TransMedics Group Inc

TransMedics Group Inc Stock Forecast & Price Prediction

Live TransMedics Group Inc Stock (TMDX) Price
$88.66

4

Ratings

  • Buy 3
  • Hold 1
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$88.66

P/E Ratio

P/E Ratio not available for TMDX

Volume Traded Today

$297,300

Dividend

Dividends not available for TMDX

52 Week High/low

99.63/36.42

TransMedics Group Inc Market Cap

$0

🛑 Alert: These ten stocks could have higher potential than $TMDX 🛑

Before you buy TMDX you’ll want to see this list of ten stocks that have huge potential. Want to see if TMDX made the cut? Enter your email below

TMDX Summary

The TransMedics Group Inc (TMDX) share price is expected to decrease by 0.18% over the next year. This is based on calculating the average 12-month share price estimate provided by 4 stock analysts who have covered TMDX. Price targets range from $75.00 at the low end to $100.00 at the high end. The current analyst consensus for TMDX is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

TMDX Analyst Ratings

About 4 Wall Street analysts have assigned TMDX 3 buy ratings, 1 hold ratings, and 0 sell ratings. This means that analysts expect TransMedics Group Inc to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on TMDX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

TMDX stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

josh jennings
TD Cowen

Buy

$100.0

maintained

Feb 5, 2024
suraj kalia
Oppenheimer

Buy

$92.0

rated

Jan 16, 2024
allen gong
J.P. Morgan

Buy

$87.0

maintained

Dec 18, 2023
patrick wood
Morgan Stanley

Hold

$75.0

maintained

Dec 4, 2023
william plovanic
Canaccord Genuity

Buy

$80.0

maintained

Nov 7, 2023
ryan daniels
William Blair

Buy

None

initiatedcoverage

Jul 19, 2023
cecilia furlong
Morgan Stanley

Hold

$81.0

initiatedcoverage

May 30, 2023
robbie marcus
J.P. Morgan

Buy

$34.0

initiatedcoverage

May 28, 2019

TMDX Company Information

TMDX
TransMedics Group Inc (TMDX)

When did it IPO

2019

Staff Count

0

Country

Sector/Industry

/

CEO

Market Cap

$0

TransMedics Group Inc(TMDX) Financial Data

In 2023, TMDX generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that TMDX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2019

N/A

Revenue From 2020

N/A

0.00 %
From Previous Year

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.00%
  • Gross profit TTM $0
  • Return on assets TTM 0.00%
  • Return on equity TTM 0.00%
  • Profit margin %
  • Book value 0.00%
  • Market capitalisation $0
  • Revenue for 2020 N/A
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • EPS this year N/A
  • EPS next year N/A

TransMedics Group Inc(TMDX) Latest News

... ...

Similar Stocks to TransMedics Group Inc TMDX

🛑 Alert: These ten stocks could have higher potential than $TMDX 🛑

Before you buy TMDX you’ll want to see this list of ten stocks that have huge potential. Want to see if TMDX made the cut? Enter your email below

...

TMDX Frequently asked questions

The highest forecasted price for TMDX is $100.00 from josh jennings at TD Cowen.

The lowest forecasted price for TMDX is $75.00 from patrick wood from Morgan Stanley

The TMDX analyst ratings consensus are 3 buy ratings, 1 hold ratings, and 0 sell ratings.